Gallentes, Lyca L.
HRN: 19-25-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
CEFUROXIME 1.5GM (VIAL)
07/21/2022
07/28/2022
IVT
1.5gm
Q8H
G2P1 (1001) IUFD, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes